Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1975-12-03
1976-12-14
Meyers, Albert T.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23253TP, 424 8, 424 12, 424 85, 424 88, 427 2, 427 4, G01N 100, G01N 2152, G01N 3122
Patent
active
039976572
ABSTRACT:
A dry diagnostic reagent composed of specially prepared, fixed and stabilized fetal calf thymocytes on microscope slides ready for use in an immunofluorescent test for the detection of human anti-nuclear factor in human serum or plasma in the diagnosis of systemic lupus erythematosus and other autoimmune diseases.
REFERENCES:
dubois, JAMA, vol. 225, Aug. 6, 1973, p. 637.
Burrows, J. Med. Soc., NJ, vol. 68, 1971, pp. 647-649.
Miescher, J. of Immuno., vol. 85, 1960, pp. 27-36.
Friou, J. Immunol., vol. 80, 1958, pp. 324-329.
Iwasaki, Surg. Gyn & Obs., vol. 124, Jan. 1967, pp. 1-24.
Widelock, Am. J. Pub. Health, vol. 51, 1961, pp. 829-835.
Mellors, Anal. Cytology, 2nd ed. 1959, McGraw-Hill, N.Y. pp. 1-28, 438-441.
Dziobkowski Beatrice Frances
Stiles Gerald Earl
American Cyanamid Company
Costello, Jr. C. F.
Fogelson A. P.
Meyers Albert T.
Richards J. W.
LandOfFree
Dry slide reagent employed in immunofluorescent test for detecti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dry slide reagent employed in immunofluorescent test for detecti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dry slide reagent employed in immunofluorescent test for detecti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1345309